The latest from Axio
Forward BIOLABS
1 POSTS-
Axio BioPharma Named ICP Round 1 Awardee, Advancing AI-Ready Biologics Manufacturing in Wisconsin
Madison, WI (February 3, 2026) — Axio BioPharma, an AI-ready biologics contract development and manufacturing organization (CDMO), today announced it has been selected as a Round 1…
Get the next update in your inbox
Occasional notes on biologics, AI-driven process development, and what the team is building. No marketing fluff.
Tell us what your program needs to share with another company
Use your message to explain which teams need to share information and what makes that difficult.